Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-19-008351
Filing Date
2019-05-03
Accepted
2019-05-03 08:01:11
Documents
6
Period of Report
2019-05-03

Document Format Files

Seq Description Document Type Size
1 6K nc10001151x1_6k.htm 6-K 25069
2 EXHIBIT 99.1 nc10001151x1_ex99-1.htm EX-99.1 40409
3 EXHIBIT 99.2 nc10001151x1_ex99-2.htm EX-99.2 2129
4 nc100001151x1_ex99-2image01.jpg GRAPHIC 248462
5 nc100001151x1_ex99-2image02.jpg GRAPHIC 84389
6 nc100001151x1_ex99-2image03.jpg GRAPHIC 75915
  Complete submission text file 0001140361-19-008351.txt   632152
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 19794082
SIC: 2834 Pharmaceutical Preparations